Cannabidiol Change Will Have No Immediate Effect
CBD Change will have no immediate effect
Today the Compound Cannabidiol or CBD is rescheduled and is supposedly free for GPs to prescribe. MCANZ is aware of several products that may be available in future, none of which are pharmaceutical grade.
“MCANZ wants to remind politicians that this change heralds no immediate positive effect, particularly for Treatment refractory Epilepsy, the condition most associated with CBD.”
“There is a product that already qualifies, from the Canadian company Tilray, however, the doses required for Paediatric Epilepsy mean it could cost in excess of 100k per anum for a teenager”.
“Our peers in Australia, have had the State Governments help facilitate compassionate supply and funding the product for some patients, it's telling that the current govt refuses to follow their example, and it has been left to MCANZ to advocate for alternative Cannabis products in the interim with no hope of subsidy, even for children whose epilepsy hasn’t responded adequately to multiple brain Surgeries.” Says MCANZ Coordinator Shane Le Brun,